References
- Committee on Safety of Medicines. 1978, Personal communication
- Day A. T., Golding J. R. Hazards of penicillamine therapy in the treatment of rheumatoid arthritis. Postgrad Med J 1974; 50(Suppl. 2)71
- Day A. T., Golding J. R., Lee P. N., Butterworth A. D. Penicillamine in rheumatoid disease: a long‐term study. Br Med J 1974; 1: 180
- Dippy J. E. Penicillamine in rheumatoid arthritis—A 2‐year retrospective study in 70 patients. Br J Clin Pract 1977; 31(1, 2, 3)5
- Gibson T., Burry H. C., Ogg C. Goodpasture syndrome & c‐penicillamine. Ann Intern Med 1976; 84: 100, (vol I)
- Hewitt J., Benveniste M., Lessana‐Leibowitch M. Pemphigus induced by D‐penicillamine. Br Med J 1975; 3: 371
- Hill Hilary F.H. Treatment of rheumatoid arthritis with penicillamine. Semin Arthritis Rheum 1977; 6: 361, (vol. 4)
- Hill H., Hill A. Penicillamine: 750 mg is not the dose. Ann Rheum Dis 1978; 37: 288
- Hill Hilary F.H., Hill A. G. S., Brown R. M., Day A. T., Golding J. R., Lyle W. H. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response‐related flexible regime. Ann Rheum Dis.
- Huskisson E. C. Penicillamine and the rheumatologist: a review. Pharmatherapeutica 1976; 1: 24
- Inman W. H. W. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J 1977; 1: 1500
- Kay G. L. Myelotoxicity of D‐penicillamine. Ann Rheum Dis. April
- Lyle W. H., Pearcey D. F., Hui M. Inhibition of penicillamine‐induced Cupruresis by oral iron. Proc R Soc Med 1977; 70(Suppl. 3)48
- Marsden R. A., Dawber R. P. P., Millard P. R., Mowat A. G. Herptiform pemphigus induced by penicillamine. Br J Dermatol 1977; 97: 451
- Marsden R. A., Ryan T. J., Vanhegan R. I., Walshe M., Hill H., Mowat A. G. Pemphigus foliaceous induced by penicillamine. Br Med J 1976; 2: 1423
- McCormick J. N., Wood P., Bell D. Penicillamine in Rheumatoid Disease, E. Munthe. Fabritius & Sønner, Oslo 1977; 268–278
- Pegum J. S., Pembroke A. C. Benign mucous‐membrane pemphigoid associated with penicillamine treatment. Br Med J 1977; 1: 1473
- Peters D. K. 1976, Personal communication
- Rees A. J., Peters D. K., Compston D. A. S., Batchelor J. R. Strong association between HLA‐DRW2 and antibody‐mediated Goodpasture's syndrome. Lancet 1978; 1: 966
- Scherak O., Kolarz G., Holubar K. Pemphigus erythematosus‐like rash in a patient on penicillamine. Br Med J 1977; 1: 838
- Sparrow G. P. Penicillamine pemphigus and the nephrotic syndrome occurring simultaneously. Br J Dermatol 1978; 98: 103
- Tsang I. K., Patterson D. A., Stein H. B., Robinson H. S., Ford D. K. D‐penicillamine in the treatment of rheumatoid arthritis. Arthritis Rheum 1977; 20: 660
- Webley M., Coomes E. N. Is penicillamine therapy in RA influenced by previous gold?. Br Med J 1978; 2: 91
- Weiss A. S., Markenson J. A., Weiss M. S., Kammerer W. H. Toxicity of D‐penicillamine in rheumatoid arthritis: A report of 63 patients including 2 with aplastic anaemia and one with nephrotic syndrome. Am J Med 1978; 64: 114